Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - December 2013


Biological Interpretation of Next-Generation Sequencing Data

02 Dec 2013 - 06 Dec 2013 - EMBL-EBI,Hinxton, Cambridge, UK



Bookmark and Share


Overview

The course covers analysis of NGS data. Using ChIP-Seq and RNA-Seq datasets as an example, the course will provide ideas and practical advice for the interpretation of NGS data sets in a genomic context.

Topics will include: RNA-Seq and ChIP-Seq data handling, quality assessment and visualisation; region identification and differential expression; data integration and external databases (ENCODE); statistical analysis using R/bioconductor.

What will I learn?

Lectures will give insight into how biological knowledge can be generated from NGS data and illustrate different ways of analysing and integrating such data. Practicals will consist of computer exercises that will enable the participants to apply statistical methods to the analysis of NGS data under the guidance of the lecturers and teaching assistants.

Familiarity with the technology and biological use cases of NGS is required, as is prior experience with standard RNA-Seq and/or ChIP-Seq workflows. Knowledge of R/Bioconductor and the Unix/Linux operating system are also required.

Is it right for me?

This course is aimed at advanced PhD students and post-doctoral researchers who are already applying next generation sequencing (NGS) technologies and bioinformatics methods in their research.

The aim of this course is to familiarise the participants with advanced data analysis methodologies for the interpretation and integration of data derived from different NGS applications including RNA-seq, ChIP-seq, DNA-methylation sequencing, genome-wide association studies (GWAS) and DNA variant detection.



Further information
Scientific News
Counting Cancer-busting Oxygen Molecules
Researchers from the Centre for Nanoscale BioPhotonics (CNBP), an Australian Research Centre of Excellence, have shown that nanoparticles used in combination with X-rays, are a viable method for killing cancer cells deep within the living body.
Crowdfunding the Fight Against Cancer
From budding social causes to groundbreaking businesses to the next big band, crowdfunding has helped connect countless worthy projects with like-minded people willing to support their efforts, even in small ways. But could crowdfunding help fight cancer?
Cancer Cells Kill Off Healthy Neighbours
Cancer cells create space to grow by killing off surrounding healthy cells, according to UK researchers working with fruit flies.
Cancer Drug Target Visualized at Atomic Resolution
New study using cryo-electron microscopy shows how potential drugs could inhibit cancer.
Genetic Mechanism Behind Cancer-Causing Mutations
Researchers at Indiana University has identified a genetic mechanism that is likely to drive mutations that can lead to cancer.
Future of Medicine Could be Found in a Tiny Crystal Ball
A Drexel University materials scientist has discovered a way to grow a crystal ball in a lab. Not the kind that soothsayers use to predict the future, but a microscopic version that could be used to encapsulate medication in a way that would allow it to deliver its curative payload more effectively inside the body.
"Gene Fusion" Drives Childhood Brain Cancers
Study co-led by Penn scientists highlights potential targets for future cancer therapies.
Enzyme Links Age-Related Inflammation, Cancer
Researchers have shown that an enzyme key to regulating gene expression -- and also an oncogene when mutated -- is critical for the expression of numerous inflammatory compounds that have been implicated in age-related increases in cancer and tissue degeneration.
Viral Gene Editing System Corrects Genetic Liver Disease
Penn study has implications for developing safe therapies for an array of rare diseases via new gene cut-and-paste methods.
Improving Delivery of Poorly Soluble Drugs Using Nanoparticles
A technology that could forever change the delivery of drugs is undergoing evaluation by the Technology Evaluation Consortium™ (TEC). Developed by researchers at Northeastern University, the technology is capable of creating nanoparticle structures that could deliver drugs into the bloodstream orally – despite the fact that they are normally poorly soluble.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!